WILMINGTON, N.C., Feb. 12 /PRNewswire-FirstCall/ -- aaiPharma Inc.
(Nasdaq: AAII) announced today that Mr. David Hurley, Chief Operating Officer
of aaiPharma, is leaving the Company.
"We have no plans to fill the role of Chief Operating Officer at this
time," stated Dr. Philip S. Tabbiner, President and Chief Executive Officer of
aaiPharma. "We wish David the best of luck in his new position as President
and CEO of Artisan Pharmaceuticals."
About aaiPharma
aaiPharma Inc. is a leading, science-based pharmaceutical company focused
on pain management, with corporate headquarters in Wilmington, North Carolina.
With more than 24 years of drug development expertise, the Company is focused
on developing, acquiring, and marketing well-known, branded medicines in its
targeted therapeutic areas. aaiPharma 's development efforts are focused on
developing improved medicines from established molecules through its
significant research and development capabilities. For more information on
the Company, including its product development organization AAI Development
Services, please visit aaiPharma's website at http://www.aaipharma.com .
SOURCE aaiPharma Inc.
 back to top
Related links:
http://www.aaipharma.com
CONTACT:
Media, Andrea L. Johnston, Vice President,
Corporate Communications, +1-910-254-7340, or Investors, James B.
Sloan, Jr., Senior Vice President, Corporate Finance,
+1-910-254-7690, both of aaiPharma Inc.
|
